Distributors of Lab reagents
Suppliers of Lab rec.
References of Lab monoclonals
Compare Assays lab reagents for research
Suppliers for Lab reagents
NATtrol Human Parvovirus B19 (10,000 IU/mL) (1 mL) |
||
NATPARVO-0001 | Zeptometrix | 1 mL |
NATtrol Human Parvovirus B19 (100,000 IU/mL) (1 mL) |
||
NATPARVO-0002 | Zeptometrix | 1 mL |
NATtrol Human Parvovirus B19 (1,000,000 IU/mL) (1 mL) |
||
NATPARVO-0003 | Zeptometrix | 1 mL |
NATtrol Human Parvovirus B19 (10,000,000 IU/mL) (1 mL) |
||
NATPARVO-0004 | Zeptometrix | 1 mL |
NATtrol Human Parvovirus B19 (100,000,000 IU/mL) (1 mL) |
||
NATPARVO-0005 | Zeptometrix | 1 mL |
NATtrol Adenovirus Type 40 (Stool Matrix) (0.5 mL) |
||
NATADV40-GP | Zeptometrix | 0.5 mL |
NATtrol Adenovirus Type 41 (Stool Matrix) (0.5 mL) |
||
NATADV41-GP | Zeptometrix | 0.5 mL |
Polyclonal ETO polyclonal antibody |
|||
APR00372G | Leading Biology | 0.05ml | 580.8 EUR |
Polyclonal SHH Polyclonal Antibody |
|||
APR00434G | Leading Biology | 0.1mg | 580.8 EUR |
Polyclonal ETO polyclonal antibody |
|||
APR00435G | Leading Biology | 0.1ml | 633.6 EUR |
Polyclonal p53 polyclonal antibody |
|||
APR00443G | Leading Biology | 0.05mg | 633.6 EUR |
Polyclonal G9a polyclonal antibody |
|||
APR00448G | Leading Biology | 0.1ml | 580.8 EUR |
Polyclonal PML polyclonal antibody |
|||
AMR09397G | Leading Biology | 0.05mg | 580.8 EUR |
Polyclonal YY1 polyclonal antibody |
|||
APR14018G | Leading Biology | 0.1ml | 580.8 EUR |
Polyclonal RARA polyclonal antibody |
|||
APR00370G | Leading Biology | 0.05ml | 580.8 EUR |
Our used monoclonals in Pubmed.
Dermatophyte Test Medium (DTM Test Agar) (Powder) |
|||
MBS653290-5x500g | MyBiosource | 5x500g | 1645 EUR |
Test Product |
|||
ZX001 | AAT Bioquest | 1mg | Ask for price |
Test Product |
|||
ZX002 | AAT Bioquest | 5mg | Ask for price |
Test product |
|||
testttt | National Diagnostics | 0 | Ask for price |
LISTERIA TEST |
|||
AKE0007 | Diatheva | 96 TEST-1 PLATE | 795.7 EUR |
Compare monoclonal lab reagents for research
Suppliers for Lab Assays
BV-MR-LBD. Recombinant baculovirus expressing Mineralocorticoid receptor LBD. |
||
S27 | AB Vector LLC | 1 ml |
Description: Drug discovery, Nuclear receptors, baculovirus |
||
MR-LBD. Purified GST-tagged MR LBD in complex with Hsp90. Applications: Ligand-binding and coregulator displacement assays. |
||
S28 | AB Vector LLC | 50 ug |
Description: Drug discovery, Nuclear receptors, purified recombinant protein |
||
BV-GR-LBD. Recombinant baculovirus expressing Glucocorticoid receptor LBD. |
||
S33 | AB Vector LLC | 1 ml |
Description: Drug discovery, Nuclear receptors, baculovirus |
||
BV-GR. Recombinant baculovirus expressing Glucocorticoid receptor. |
||
S35 | AB Vector LLC | 1 ml |
Description: Drug discovery, Nuclear receptors, baculovirus |
||
BV-PXR-LBD. Recombinant baculovirus expressing Pregnane X receptor LBD. |
||
S36 | AB Vector LLC | 1 ml |
Description: Drug discovery, Nuclear receptors, baculovirus |
||
BV-AhR. Recombinant baculovirus expressing Aryl hydrocarbon receptor LBD. |
||
S41 | AB Vector LLC | 1 ml |
Description: Drug discovery, Nuclear receptors, baculovirus |
||
AhR-LBD. Purified GST-tagged human Arylhydrocarbon receptor LBD in complex with Hsp90. Applications: Ligand-binding and coregulator displacement assays. |
||
SAh90 | AB Vector LLC | 50 ug |
Description: Drug discovery, Nuclear receptors, purified recombinant protein |
Polyclonal ETO polyclonal antibody |
|||
APR00372G | Leading Biology | 0.05ml | 580.8 EUR |
Polyclonal SHH Polyclonal Antibody |
|||
APR00434G | Leading Biology | 0.1mg | 580.8 EUR |
Polyclonal ETO polyclonal antibody |
|||
APR00435G | Leading Biology | 0.1ml | 633.6 EUR |
Polyclonal p53 polyclonal antibody |
|||
APR00443G | Leading Biology | 0.05mg | 633.6 EUR |
Polyclonal G9a polyclonal antibody |
|||
APR00448G | Leading Biology | 0.1ml | 580.8 EUR |
Polyclonal PML polyclonal antibody |
|||
AMR09397G | Leading Biology | 0.05mg | 580.8 EUR |
Polyclonal YY1 polyclonal antibody |
|||
APR14018G | Leading Biology | 0.1ml | 580.8 EUR |
Polyclonal RARA polyclonal antibody |
|||
APR00370G | Leading Biology | 0.05ml | 580.8 EUR |
Our used References in Pubmed.
CTAG2 Recombinant Protein (Mouse) (Recombinant-P Tag) |
|||
RP126446 | ABM | 100 ug | Ask for price |
S. aureus Recombinant Protein A Recombinant Protein |
|||
PROTB3GGB2 | BosterBio | 20ug | 243 EUR |
TWEAK, recombinant / TNFSF12, recombinant (Human) - ELISA Kit |
|||
EK-054-85 | PHOENIX PEPTIDE | 96 wells | 660.96 EUR |
Mouse Recombinant anti-Rat CD3 Recombinant Antibody |
|||
xAP-0878 | Angio Proteomie | 100ug | 280 EUR |
Rat Recombinant anti-Mouse CD25 Recombinant Antibody |
|||
xAP-0593 | Angio Proteomie | 100ug | 280 EUR |
Compare polyclonal lab reagents for research
Suppliers for Lab reagents
Recombinant RNA-directed RNA polymerase L (L) |
||
MBS1147877-002mgYeast | MyBiosource | 0.02mg(Yeast) |
Recombinant RNA-directed RNA polymerase L (L) |
||
MBS1147877-01mgEColi | MyBiosource | 0.1mg(E-Coli) |
Recombinant RNA-directed RNA polymerase L (L) |
||
MBS1147877-01mgYeast | MyBiosource | 0.1mg(Yeast) |
RNA Storage |
||
E0308-01 | EURx | 10x1.5ml |
RNA-directed RNA polymerase beta chain Antibody |
||
MBS7153538-INQUIRE | MyBiosource | INQUIRE |
RNA-directed RNA polymerase beta chain Antibody |
||
MBS7162494-INQUIRE | MyBiosource | INQUIRE |
RNA-directed RNA polymerase beta chain Antibody |
||
MBS7164695-INQUIRE | MyBiosource | INQUIRE |
Recombinant Humanp21 Recombinant Protein |
|||
92-035 | ProSci | 0.05 mg | 821.4 EUR |
TWEAK, recombinant / TNFSF12, recombinant (Human) |
|||
054-85 | PHOENIX PEPTIDE | 10 μg | 261.36 EUR |
TAGLN Recombinant Protein (Rat) (Recombinant- Tag) |
|||
RP232205 | ABM | 100 ug | Ask for price |
TAGLN2 Recombinant Protein (Rat) (Recombinant Tag) |
|||
RP232208 | ABM | 100 ug | Ask for price |
TAGLN3 Recombinant Protein (Rat) (Recombinant Tag) |
|||
RP232211 | ABM | 100 ug | Ask for price |
TAGLN3 Recombinant Protein (Rat) (Recombinant Tag) |
|||
RP232214 | ABM | 100 ug | Ask for price |
TAGAP Recombinant Protein (Human) (Recombinant- Tag) |
|||
RP030880 | ABM | 100 ug | Ask for price |
TAGLN Recombinant Protein (Human) (Recombinant- Tag) |
|||
RP030883 | ABM | 100 ug | Ask for price |
Our used recombinants in Pubmed.
Anti- GPR162 Antibody Antibody |
|||
GWB-AAD3BE | GenWay Biotech | 0.05 ml | Ask for price |
Anti- GPR162 Antibody Antibody |
|||
GWB-C5010A | GenWay Biotech | 0.05 ml | Ask for price |
Anti-CD31 Antibody Antibody |
|||
MBS8304163-003mL | MyBiosource | 0.03mL | 185 EUR |
Anti-CD31 Antibody Antibody |
|||
MBS8304163-01mL | MyBiosource | 0.1mL | 255 EUR |
Anti-CD31 Antibody Antibody |
|||
MBS8304163-02mL | MyBiosource | 0.2mL | 335 EUR |
Compare polyclonal lab reagents for research
Suppliers for Lab ELISAs
HIV-1 gp120 |
||
V7074 | Antagene | 0.2mg |
HIV-1 gp120 |
||
GWB-439A1B | GenWay Biotech | 0.1 mg |
HIV-2 gp160 |
||
hiv-013 | ProSpec Tany | 100µg |
Description: Recombinant HIV-2 gp160 |
||
HIV-1 gp120 |
||
hiv-102 | ProSpec Tany | 100µg |
Description: Recombinant HIV-1 gp120 nef Mosaic |
||
HIV-1 p1724 |
||
hiv-121 | ProSpec Tany | 100µg |
Description: Recombinant HIV-1 gag p17, p24 |
||
HIV-1 gp120 |
||
GWB-696AF8 | GenWay Biotech | 0.1 mg |
HIV-2 env.gp36 |
||
GWB-778C9B | GenWay Biotech | 1 mg |
REC-1 |
|||
ABC-TC0956 | AcceGen | 1 vial | Ask for price |
pGADT7-Rec |
|||
PVTY00072 | Nova Lifetech | 2ug | 280 EUR |
pGADT7-Rec |
|||
PVT4025 | Nova Lifetech | 2ug | 216 EUR |
REC-2615 (HCl) |
|||
530142 | MedKoo Biosciences | 10.0mg | 295 EUR |
Rec FLA-ST |
|||
tlrl-flic-10 | InvivoGen FR | 10 µg | 295.05 EUR |
Rec FLA-ST |
|||
tlrl-flic-50 | InvivoGen FR | 50 µg | 731.85 EUR |
rec EGF (human) |
|||
4030572.01 | Bachem | 0.1 mg | 102.27 EUR |
rec EGF (human) |
|||
4030572.05 | Bachem | 0.5 mg | 271.85 EUR |
Our used antibodies in Pubmed.
Polyclonal Hira polyclonal antibody |
|||
APR00449G | Leading Biology | 0.1ml | 580.8 EUR |
Polyclonal SPI1 polyclonal antibody |
|||
APR00451G | Leading Biology | 0.1ml | 580.8 EUR |
Polyclonal BMI1 polyclonal antibody |
|||
APR00457G | Leading Biology | 0.1ml | 580.8 EUR |
Polyclonal CHD4 polyclonal antibody |
|||
APR00459G | Leading Biology | 0.05mg | 580.8 EUR |
Polyclonal Rtf1 polyclonal antibody |
|||
APR11187G | Leading Biology | 0.05mg | 633.6 EUR |
Assay Lab Reagents for Research
Promoted Lab rec.
Polyclonal ETO polyclonal antibody |
|||
APR00372G | Leading Biology | 0.05ml | 580.8 EUR |
Polyclonal SHH Polyclonal Antibody |
|||
APR00434G | Leading Biology | 0.1mg | 580.8 EUR |
Polyclonal ETO polyclonal antibody |
|||
APR00435G | Leading Biology | 0.1ml | 633.6 EUR |
Polyclonal p53 polyclonal antibody |
|||
APR00443G | Leading Biology | 0.05mg | 633.6 EUR |
Polyclonal G9a polyclonal antibody |
|||
APR00448G | Leading Biology | 0.1ml | 580.8 EUR |
Polyclonal PML polyclonal antibody |
|||
AMR09397G | Leading Biology | 0.05mg | 580.8 EUR |
Polyclonal ETO polyclonal antibody |
|||
APR00372G | Leading Biology | 0.05ml | 580.8 EUR |
Polyclonal SHH Polyclonal Antibody |
|||
APR00434G | Leading Biology | 0.1mg | 580.8 EUR |
Polyclonal ETO polyclonal antibody |
|||
APR00435G | Leading Biology | 0.1ml | 633.6 EUR |
Polyclonal p53 polyclonal antibody |
|||
APR00443G | Leading Biology | 0.05mg | 633.6 EUR |
Polyclonal G9a polyclonal antibody |
|||
APR00448G | Leading Biology | 0.1ml | 580.8 EUR |
Polyclonal PML polyclonal antibody |
|||
AMR09397G | Leading Biology | 0.05mg | 580.8 EUR |
Polyclonal YY1 polyclonal antibody |
|||
APR14018G | Leading Biology | 0.1ml | 580.8 EUR |
Our used antibodies in Pubmed.
pGADT7- Rec- 53 |
|||
PVT11254 | Nova Lifetech | 2ug | 260 EUR |
rec Leptin (human) |
|||
4038283.02 | Bachem | 0.2 mg | 102.27 EUR |
rec Leptin (human) |
|||
4038283.1 | Bachem | 1 mg | 271.85 EUR |
rec Leptin (mouse) |
|||
4038284.02 | Bachem | 0.2 mg | 102.27 EUR |
rec Leptin (mouse) |
|||
4038284.1 | Bachem | 1 mg | 271.85 EUR |
rec Leptin (human) |
|||
H-5578.0200 | Bachem | 0.2mg | 194.4 EUR |
rec Leptin (human) |
|||
H-5578.1000 | Bachem | 1.0mg | 457.2 EUR |
rec Leptin (mouse) |
|||
H-5582.0200 | Bachem | 0.2mg | 194.4 EUR |
rec Leptin (mouse) |
|||
H-5582.1000 | Bachem | 1.0mg | 457.2 EUR |
Rec-KPC protein |
|||
MBS313821-01mg | MyBiosource | 0.1mg | 860 EUR |
A Complex Life Habitable Zone Based On Lipid Solubility Theory
To discover doubtlessly liveable exoplanets, area missions make use of the liveable zone (HZ), which is the area round a star (or a number of stars) the place standing our bodies of water might exist on the floor of a rocky planet. Follow-up atmospheric characterization might yield biosignatures signifying life.
Although most iterations of the HZ are agnostic relating to the character of such life, a latest research argues {that a} advanced life HZ could be significantly smaller than that utilized in classical definitions. Here, I exploit a sophisticated power stability mannequin to indicate that such an HZ could be significantly wider than initially predicted given revised CO2 limits and (for the primary time) N2 respiration limits for advanced life.
The width of this advanced life HZ (CLHZ) will increase by ~35% from ~0.95-1.2 AU to 0.95-1.31 AU in our photo voltaic system. Similar extensions are proven for stars with stellar efficient temperatures between 2,600-9,000 Okay. I outline this CLHZ utilizing lipid solubility principle, diving knowledge, and outcomes from animal laboratory experiments. I additionally focus on implications for biosignatures and technosignatures. Finally, I focus on the applicability of the CLHZ and different HZ variants to the seek for each easy and sophisticated life.
Evolution of Microbial Growth Traits Under Serial Dilution
Selection of mutants in a microbial inhabitants depends upon a number of mobile traits. In serial-dilution evolution experiments, three key traits are the lag time when transitioning from hunger to development, the exponential development price, and the yield (variety of cells per unit useful resource).
Here we examine how these traits evolve in laboratory evolution experiments utilizing a minimal mannequin of inhabitants dynamics, the place the one interplay between cells is competitors for a single limiting useful resource.
We discover that the fixation chance of a useful mutation depends upon a linear mixture of its development price and lag time relative to its speedy ancestor, even below clonal interference. The relative selective strain on development price and lag time is ready by the dilution issue; a bigger dilution issue favors the difference of development price over the difference of lag time.
The mannequin exhibits that yield, nonetheless, is below no direct choice. We additionally present how the difference speeds of development and lag rely on experimental parameters and the underlying provide of mutations.
Finally, we examine the evolution of covariation between these traits throughout populations, which reveals that the inhabitants development price and lag time can evolve a nonzero correlation even when mutations have uncorrelated results on the 2 traits. Altogether these outcomes present helpful steerage to future experiments on microbial evolution.
Zika Virus Isolation, Purification, and Titration
Zika virus (ZIKV) is a vital pathogen transmitted to people by the mosquito vector Aedes aegypti. ZIKV is ready to infect a number of tissues and organs and, importantly, has been related to microcephaly and central nervous system abnormalities in fetuses and new child infants of moms uncovered to ZIKV throughout being pregnant, in addition to neurological ailments resembling Guillain-Barré syndrome in adults.
Tright here is at the moment no vaccine or drug licensed to stop or deal with ZIKV infections. The use of ZIKV isolation in illness prognosis has been largely changed by new strategies. However, virus isolation continues to be thought of as a gold customary for the detection of ZIKV and is often carried out in analysis and reference laboratories for characterization, sequencing, and quite a lot of analysis experiments together with pathogenesis, drug susceptibility, and vaccine efficacy.
The experimental procedures offered right here describe the commonest strategies used for ZIKV isolation, propagation, purification, and quantification.